Information Journal Paper
APA:
Copy. (2020). Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Research, 9(129), 0-0. SID. https://sid.ir/paper/673565/en
Vancouver:
Copy. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Research[Internet]. 2020;9(129):0-0. Available from: https://sid.ir/paper/673565/en
IEEE:
Copy, “Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates,” F1000Research, vol. 9, no. 129, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/673565/en